Ionis Pharmaceuticals Announces that Pfizer Reported Positive Results of Vupanorsen for Cardiovascular Risk Reduction and Severe Hypertriglyceridemia
November 25, 2021
0
Ionis Pharmaceuticals Announced Pfizer Update of Vupanorsen Ionis Pharmaceuticals (IONS) announced that Pfizer's (